Trials / Unknown
UnknownNCT03837886
Effects of Sodium Bicarbonate Supplementation on Intermittent and Intense Task
Sodium Bicarbonate Supplementation Promotes Changes in Performance, Muscle Activity and Strength of Individuals Trained During the Performance of Intermittent and Intense Task? Randomized, Double-blind, Crossover Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- University of Nove de Julho · Academic / Other
- Sex
- Male
- Age
- 20 Years – 42 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study was to verify if sodium bicarbonate (NaHCO3) suplementation promotes changes in the performance, muscular activity and strength of individuals trained during the intermittent and intense task . Twelve trained adult men will participate in this randomized, double-blind, crossover clinical trial. Each participant should receive two types of intervention with a 14-day interval between conditions: alkalosis (ALK) in which gelatinous capsules containing 0.3 g.kg -1 of NaHCO 3 and placebo (PLA) are administered, in which 0.3 g.kg-1 of Calcium Carbonate (CaCO3). The following results will be considered: electromyographic activity (EMG) of the quadriceps muscle, peak torque, pH, lactate, and perception of effort, recovery and pain questionnaires, which will be collected during intermittent and high intensity DI protocol. ANOVA of repeated measures will be used to verify possible differences between groups.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Sodium bicarbonate | The subjects should ingest 0.3g.kg of sodium bicarbonate 90 minutes before the beginning of the protocol task. |
| DIETARY_SUPPLEMENT | Calcium carbonate | The subjects should receive gelatinous capsules containing 0.3 g.kg -1 of Calcium Carbonate |
Timeline
- Start date
- 2019-10-20
- Primary completion
- 2019-10-30
- Completion
- 2019-11-30
- First posted
- 2019-02-12
- Last updated
- 2019-10-17
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03837886. Inclusion in this directory is not an endorsement.